The adrenal medulla in cardiovascular medicine: an untold story. Issue 5 (May 2021)

• Record Type: Journal Article
• Authors: Esler, Murray D.; Jennings, Garry; Schlaich, Markus; Lambert, Gavin; Thompson, Jane; Lambert, Elisabeth; Guo, Ling; Alvarenga, Marlies; Esler, Danielle; Eikelis, Nina; Kaye, David
• Is Part Of: Journal of hypertension. Volume 39:Issue 5(2021)
• Publication Date: 2021-05
• Subjects: adrenaline -- ageing -- arterial baroreflex -- depressive illness -- heart failure -- hypertension -- hypoglycaemia -- low pressure cardiopulmonary reflex -- stress -- sympathetic nervous system; Hypertension -- Periodicals; Hypertension -- Periodicals; 616.132005
• DOI: 10.1097/HJH.0000000000002748
• Languages: English
• ISSNs: 1473-5598

Abstract

Abstract : N/A: Unlike noradrenaline, the sympathetic neurotransmitter which overflows to the circulation, adrenaline (ADR) is a secreted hormone, with a low plasma concentration, and plasma concentration for biological action a log order lower than that of noradrenaline. The venous drainage of the left adrenal medulla into the left renal vein does expose this vein to uniquely high plasma ADR concentrations and possible risk of thrombosis at high rates of ADR secretion. There is typically a different timeframe for adrenal medullary and sympathetic nervous system responses: ADR release is short term in contrast with sympathetic activation persisting for years in heart failure and hypertension. The historic view of Walter Cannon, subject to recent review, that the sympathoadrenal system is a unified biological system, was deconstructed further with demonstration of frequent mismatching of adrenal medullary and sympathetic nervous responses. Under gravity stimulation with standing, there is prompt sympathetic activation without ADR release. In many diseases, notably obesity, hypertension, heart failure and depressive illness, an activated sympathetic nervous system and silent adrenal medulla coexist. The therapeutic corollary of this is that ADR blockade is much less commonly needed clinically than pharmacological antagonism of the sympathetic nervous system.